A biologics company with a mission to treat a range of autoimmune and inflammatory disorders.
Location: United Kingdom, England, Oxford
Total raised: $97.03M
Investors 5
| Date | Name | Website |
| - | Oxford Uni... | innovation... |
| 18.07.2022 | OrbiMed | orbimed.co... |
| - | Oxford Sci... | oxfordscie... |
| - | Advent Lif... | adventls.c... |
| 26.09.2021 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.06.2022 | Series B | $97.03M | Medicxi |
Mentions in press and media 4
| Date | Title | Description | Source |
| 04.08.2022 | Gilead Sciences to acquire Oxford University biotech spinout... | U.S. pharmaceutical giant Gilead Sciences has announced plans to acquire Oxford University biotech s... | techcrunch... |
| 29.06.2022 | MiroBio Raises $97 Million Series B Financing to Develop Che... | - | medicxi.co... |
| 29.06.2022 | MiroBio Raises $97 Million Series B Financing to Develop Che... | MiroBio Raises $97 Million Series B Financing to Develop Checkpoint Agonists for Treatment of Autoim... | globenewsw... |
| 07.01.2021 | Biggest winners, brightest futures: 10 young tech startups f... | Want to know which newly-founded tech startup from UK gained maximum popularity in 2020? Or raised t... | uktech.new... |